文献速递皮肤肿瘤

常规皮肤检查发现的黑色素瘤与死亡风险的关联

Association Between Melanoma Detected During Routine Skin Checks and Mortality.
PubMed 文献 · JAMA Dermatol · 2021-01-01

这项在澳大利亚新南威尔士州开展的前瞻性人群队列研究纳入2452例原发性皮肤黑色素瘤患者,随访至2018年(平均11.9年)。调整年龄和性别后,常规皮肤检查发现的侵袭性黑色素瘤与黑色素瘤特异性死亡风险降低59%及全因死亡风险降低36%相关;进一步调整预后因素后,黑色素瘤特异性死亡关联为0.68(95%CI 0.44-1.03;P=.13),全因死亡关联为0.75(95%CI 0.63-0.90;P=.006)。

要点

  • 常规皮肤检查发现的侵袭性黑色素瘤与较低全因死亡率相关,调整预后因素后HR为0.75(95%CI 0.63-0.90;P=.006)。
  • 调整预后因素后,常规皮肤检查与黑色素瘤特异性死亡率的关联为0.68(95%CI 0.44-1.03;P=.13),未达统计学显著。
  • 男性、既往黑色素瘤史、多痣、50岁及以上与常规皮肤检查发现黑色素瘤的 odds 较高相关。

核心结论

  • 在这项队列研究中,调整患者、社会人口学和临床病理因素后,通过常规皮肤检查诊断的黑色素瘤与显著较低的全因死亡率相关,但与黑色素瘤特异性死亡率无关。

研究设计与样本

  • 前瞻性、人群为基础的队列研究,纳入澳大利亚新南威尔士州2006年10月23日至2007年10月22日一年内诊断的黑色素瘤患者,随访至2018年,平均随访11.9(标准差0.3)年。
  • 共记录3932例黑色素瘤,最终分析2452例(62%;每例患者1个病灶)原发性原位(n=291)或侵袭性(n=2161)皮肤黑色素瘤。
  • 治疗医生在基线问卷中记录黑色素瘤检出方式及患者和临床特征,组织病理学变量来自病理报告;数据分析时间为2020年3月至2021年1月。

主要发现

  • 2452例患者中,诊断时中位年龄65岁(范围16-98岁),男性1502例(61%)。
  • 858例(35%)的黑色素瘤在常规皮肤检查中发现,1148例(47%)为自我发现,293例(12%)为检查其他皮损时偶然发现,153例(6%)报告为「其他」表现。
  • 与患者自我发现相比,常规皮肤检查发现的侵袭性黑色素瘤与黑色素瘤特异性死亡率降低59%相关(亚风险比0.41;95%CI 0.28-0.60;P<.001),与全因死亡率降低36%相关(风险比0.64;95%CI 0.54-0.76;P<.001),均调整年龄和性别。
  • 进一步调整包括溃疡和核分裂率在内的预后因素后,上述关联分别为0.68(95%CI 0.44-1.03;P=.13)和0.75(95%CI 0.63-0.90;P=.006)。
  • 与常规皮肤检查检出黑色素瘤 odds 较高相关的因素包括:男性(女性 vs 男性,OR 0.73;95%CI 0.60-0.89;P=.003)、既往黑色素瘤史( vs 无,OR 2.36;95%CI 1.77-3.15;P<.001)、多痣( vs 否,OR 1.39;95%CI 1.10-1.77;P=.02)、50岁及以上(如50-59岁 vs <40岁,OR 2.89;95%CI 1.92-4.34;P<.001)、居住在非偏远地区(如偏远或极偏远 vs 主要城市,OR 0.23;95%CI 0.05-1.04;P=.003)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Early melanoma diagnosis is associated with better health outcomes, but there is insufficient evidence that screening, such as having routine skin checks, reduces mortality. OBJECTIVE: To assess melanoma-specific and all-cause mortality associated with melanomas detected through routine skin checks, incidentally or patient detected. A secondary aim was to examine patient, sociodemographic, and clinicopathologic factors associated with different modes of melanoma detection. DESIGN, SETTING, AND PARTICIPANTS: This prospective, population-based, cohort study included patients in New South Wales, Australia, who were diagnosed with melanoma over 1 year from October 23, 2006, to October 22, 2007, in the Melanoma Patterns of Care Study and followed up until 2018 (mean [SD] length of follow-up, 11.9 [0.3] years) by using linked mortality and cancer registry data. All patients who had invasive melanomas recorded at the cancer registry were eligible for the study, but the number of in situ melanomas was capped. The treating doctors recorded details of melanoma detection and patient and clinical characteristics in a baseline questionnaire. Histopathologic variables were obtained from pathology reports. Of 3932 recorded melanomas, data were available and analyzed for 2452 (62%; 1 per patient) with primary in situ (n = 291) or invasive (n = 2161) cutaneous melanoma. Data were analyzed from March 2020 to January 2021. MAIN OUTCOMES AND MEASURES: Melanoma-specific mortality and all-cause mortality. RESULTS: A total of 2452 patients were included in the analyses. The median age at diagnosis was 65 years (range, 16-98 years), and 1502 patients (61%) were men. A total of 858 patients (35%) had their melanoma detected during a routine skin check, 1148 (47%) self-detected their melanoma, 293 (12%) had their melanoma discovered incidentally when checking another skin lesion, and 153 (6%) reported "other" presentation. Routine skin-check detection of invasive melanomas was associated with 59% lower melanoma-specific mortality (subhazard ratio, 0.41; 95% CI, 0.28-0.60; P < .001) and 36% lower all-cause mortality (hazard ratio, 0.64; 95% CI, 0.54-0.76; P < .001), adjusted for age and sex, compared with patient-detected melanomas. After adjusting for prognostic factors including ulceration and mitotic rate, the associations were 0.68 (95% CI, 0.44-1.03; P = .13), and 0.75 (95% CI, 0.63-0.90; P = .006), respectively. Factors associated with higher odds of routine skin-check melanoma detection included being male (female vs male, odds ratio [OR], 0.73; 95% CI, 0.60-0.89; P = .003), having previous melanoma (vs none, OR, 2.36; 95% CI, 1.77-3.15; P < .001), having many moles (vs not, OR, 1.39; 95% CI, 1.10-1.77; P = .02), being 50 years or older (eg, 50-59 years vs <40 years, OR, 2.89; 95% CI, 1.92-4.34; P < .001), and living in nonremote areas (eg, remote or very remote vs major cities, OR, 0.23; 95% CI, 0.05-1.04; P = .003). CONCLUSIONS AND RELEVANCE: In this cohort study, melanomas diagnosed through routine skin checks were associated with significantly lower all-cause mortality, but not melanoma-specific mortality, after adjustment for patient, sociodemographic, and clinicopathologic factors.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Watts CG, McLoughlin K, Goumas C, et al. Association Between Melanoma Detected During Routine Skin Checks and Mortality. JAMA Dermatol. 2021. PMID: 34730781. doi:10.1001/jamadermatol.2021.3884

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。